98%
921
2 minutes
20
Environmental, social and governance (ESG) criteria demand that enterprises should not be assessed solely on their financial performance, but also on their environmental, social, and governance performance. This numerical assessment of ESG criteria enables them to be evaluated with the consideration of other financial issues of enterprises' performance and thereby guides financial investments into environmentally and socially responsible firms. ESG, however, solidifies the continuance of conventional technologies but can potentially disadvantage emerging technologies. This study is the first to forecast the ESG potential of emerging chemical technologies. The Morgan Stanley Capital International (MSCI) rating system is applied to one of the top 3 global chemical processes. Ammonia (NH) is produced the Haber-Bosch (HB) process, which needs a huge fossil fuel input and high energy consumption, leading to a significant contribution to carbon dioxide (CO) emissions. In contrast, the ESG assessment rates emerging plasma technology and its spearhead companies that lead innovation and development in this field, which provide the benefits of being a clean, sustainable alternative for green NH production. Five different plasma-technology companies are considered, with the technology readiness level (TRL) ranging from 3 to 9. These are compared to five different conventional HB companies. We examine the final ESG result of the plasma technology companies, exploring their environmental advances and social viability. In this study, five different themes were selected, including eleven issues, to measure the plasma-technology company's management related to ESG risks and opportunities.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11664233 | PMC |
http://dx.doi.org/10.1039/d4su00423j | DOI Listing |
Rev Med Liege
September 2025
Service de Gastroentérologie, CHU Liège, Belgique.
Bariatric endoscopy is an increasingly recognized alternative to surgery for obesity treatment. Recent guidelines from leading medical societies (IFSO, ASMBS, ASGE, ESGE) have included endoscopic sleeve gastroplasty (ESG) and the intragastric balloon (IGB) in their recommendations. These procedures are indicated for patients with a body mass index (BMI) between 27 and 40 kg/m² who cannot or do not wish to undergo surgery.
View Article and Find Full Text PDFObes Surg
September 2025
Division of Gastroenterology and Hepatology, Department of Medicine, Weill Cornell Medicine, 1305 York Avenue, 4th Floor, New York, NY, 10021, United States.
Introduction And Aim: Despite ESG's efficacy in promoting weight loss, data on its impact on body composition is limited. This study evaluated ESG's effectiveness in improving body composition and metabolic parameters over 6 and 12 months using InBody analysis.
Methods: We prospectively analyzed patients with obesity (BMI > 30 kg/m or > 27 with comorbidities) who underwent ESG between August 2021 and May 2024.
J Metab Bariatr Surg
August 2025
Office of Medical Education, Seoul National University College of Medicine, Seoul, Korea.
Obesity represents a major global health challenge, requiring interventions that are both effective and economically sustainable. This review examines the cost-effectiveness of commonly discussed treatment options: glucagon-like peptide-1 receptor agonists (GLP-1 RAs), endoscopic sleeve gastroplasty (ESG), and metabolic/bariatric surgery (MBS). We synthesized evidence from published clinical studies and economic analyses, comparing incremental cost-effectiveness ratios (ICERs) and cost per quality-adjusted life year across obesity severity classes, with particular consideration of implications for Korea's healthcare context.
View Article and Find Full Text PDFPLoS One
September 2025
Shanghai Institute of Justice, Shanghai University of Political Science and Law, Shanghai, China.
The substantial impact of corporate Environmental, Social, and Governance (ESG) performance, predominantly measured by non-financial metrics, on external auditors is investigated in this paper. Using a sample of Chinese-listed companies from 2011 to 2021, we examine how auditors respond to corporate ESG performance from the perspective of audit pricing. The findings reveal a U-shaped, non-linear relationship between corporate ESG performance and audit pricing.
View Article and Find Full Text PDF